Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360 |
Resumo: | Introduction: Langerhans cell histiocytosis is a heterogeneous disease, more frequently diagnosed during childhood. Between 1/2001 and 12/2013, 20 adult patients were admitted at both Hospitals. This work aimed at ccharacterizing this population.Material and Methods: Retrospective study, review of clinical records.Results: 16 patients were eligible to analysis. The median age at diagnosis was 34 years (15-48); 10 males and 6 females. The referral motive was: respiratory complaints – 37.5%; bone changes – 37.5%; dental complaints - 25%; constitutional symptoms - 19%; mucocutaneous lesions – 6% and one patient (6%) was accidentally diagnosed after a thyroidectomy. The tissue of histological diagnosis was: bone - 50%; pulmonary tissue – 37.5%; liver, genital mucosa and thyroid - 6%, respectively. Staging was: single organ involvement (uni/multifocal) - 69% and multisystem disease in 31%. Clinical re-evaluation of these cases is being done at the moment. The median follow up was 5 years (1 month – 11 years) and the overall survival was 92%. Currently 19% are alive without signs of disease; 44% are alive with disease; 25% are under treatment and 12% died.Discussion: These results agree with published literature. Considering the actual guidelines 56% patients were incompletely staged, which probably lead to suboptimal treatment. There is heterogeneity of clinical procedures aiming at staging and treatment of these patients.Conclusion: The diagnosis of adulthood Langerhans cell histiocytosis is difficult considering the diversity of clinical behavior. Frequently this also leads to diagnosis delay. Prospective international clinical trials enrolling adult patients are important.Keywords: Adult; Histiocytosis, Langerhans-Cell. |
id |
RCAP_e39da51ab9b60d8543689ce6502ab9f9 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/5360 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese HospitalsHistiocitose de Largerhans no Adulto: Experiência de Dois Hospitais PortuguesesIntroduction: Langerhans cell histiocytosis is a heterogeneous disease, more frequently diagnosed during childhood. Between 1/2001 and 12/2013, 20 adult patients were admitted at both Hospitals. This work aimed at ccharacterizing this population.Material and Methods: Retrospective study, review of clinical records.Results: 16 patients were eligible to analysis. The median age at diagnosis was 34 years (15-48); 10 males and 6 females. The referral motive was: respiratory complaints – 37.5%; bone changes – 37.5%; dental complaints - 25%; constitutional symptoms - 19%; mucocutaneous lesions – 6% and one patient (6%) was accidentally diagnosed after a thyroidectomy. The tissue of histological diagnosis was: bone - 50%; pulmonary tissue – 37.5%; liver, genital mucosa and thyroid - 6%, respectively. Staging was: single organ involvement (uni/multifocal) - 69% and multisystem disease in 31%. Clinical re-evaluation of these cases is being done at the moment. The median follow up was 5 years (1 month – 11 years) and the overall survival was 92%. Currently 19% are alive without signs of disease; 44% are alive with disease; 25% are under treatment and 12% died.Discussion: These results agree with published literature. Considering the actual guidelines 56% patients were incompletely staged, which probably lead to suboptimal treatment. There is heterogeneity of clinical procedures aiming at staging and treatment of these patients.Conclusion: The diagnosis of adulthood Langerhans cell histiocytosis is difficult considering the diversity of clinical behavior. Frequently this also leads to diagnosis delay. Prospective international clinical trials enrolling adult patients are important.Keywords: Adult; Histiocytosis, Langerhans-Cell.Introdução: A histiocitose de células de Langerhans é uma doença heterogénea e mais frequente em crianças. Entre 1/2001 e 12/2013 admitimos 20 doentes com HCL nas duas instituições. O objectivo deste trabalho foi caracterizar esta população, avaliando as formas de apresentação, o estadiamento e tratamento.Material e Métodos: Estudo retrospectivo; consulta do processo clínico.Resultados: Dos 16 doentes analisáveis verificamos uma mediana de idade 34 anos (15-48), 10 mulheres e 6 homens. Os motivos que determinaram a referenciação dos doentes foram: queixas respiratórias em 37,5%; alterações ósseas em 37,5%; queixas dentárias em 25%; sintomas constitucionais em 19%; lesões mucocutâneas em 6% e outro foi um achado histológico inesperado após tiroidectomia. O diagnóstico histológico foi obtido em: osso em 50%; pulmão em 37,5%; fígado, mucosa vulvar e peça de tiroidectomia em 6%, respectivamente. O estadiamento assumido na prática clínica foi: envolvimento de órgão único (uni/multifocal) em 69% e doença multissistémica em 31%. A mediana de seguimento foi cinco anos (dois meses-11 anos) e a sobrevivência global 92%. Actualmente: 19% estão vivos sem doença; 44% estão vivos com doença; 25% estão em tratamento e 12% morreram.Discussão: Estes resultados estão de acordo com a literatura. No entanto, segundo as recomendações actuais consideramos que 56% doentes efectuaram estudo complementar incompleto condicionando subestadiamento e provavelmente subtratamento. Verifica-se heterogeneidade de procedimentos no estadiamento e tratamento.Conclusão: Frequentemente há dificuldades e atraso no diagnóstico desta entidade clínica. São importantes estudos prospectivos internacionais na população adulta.Palavras-chave: Adulto; Histiocitose de Células de Langerhans.Ordem dos Médicos2014-12-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfimage/jpegimage/jpegimage/jpegapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360oai:ojs.www.actamedicaportuguesa.com:article/5360Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 726-730Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 726-7301646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/4149https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/4248https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7167https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7168https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7169https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7451Brito, Margarida Dantas deMartins, ÂngeloAndrade, JoaquimGuimarães, JoséMariz, Joséinfo:eu-repo/semantics/openAccess2022-12-20T11:04:19Zoai:ojs.www.actamedicaportuguesa.com:article/5360Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:04.448720Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals Histiocitose de Largerhans no Adulto: Experiência de Dois Hospitais Portugueses |
title |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals |
spellingShingle |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals Brito, Margarida Dantas de |
title_short |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals |
title_full |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals |
title_fullStr |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals |
title_full_unstemmed |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals |
title_sort |
Adulthood Langerhans Cell Histiocytosis: Experience of Two Portuguese Hospitals |
author |
Brito, Margarida Dantas de |
author_facet |
Brito, Margarida Dantas de Martins, Ângelo Andrade, Joaquim Guimarães, José Mariz, José |
author_role |
author |
author2 |
Martins, Ângelo Andrade, Joaquim Guimarães, José Mariz, José |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Brito, Margarida Dantas de Martins, Ângelo Andrade, Joaquim Guimarães, José Mariz, José |
description |
Introduction: Langerhans cell histiocytosis is a heterogeneous disease, more frequently diagnosed during childhood. Between 1/2001 and 12/2013, 20 adult patients were admitted at both Hospitals. This work aimed at ccharacterizing this population.Material and Methods: Retrospective study, review of clinical records.Results: 16 patients were eligible to analysis. The median age at diagnosis was 34 years (15-48); 10 males and 6 females. The referral motive was: respiratory complaints – 37.5%; bone changes – 37.5%; dental complaints - 25%; constitutional symptoms - 19%; mucocutaneous lesions – 6% and one patient (6%) was accidentally diagnosed after a thyroidectomy. The tissue of histological diagnosis was: bone - 50%; pulmonary tissue – 37.5%; liver, genital mucosa and thyroid - 6%, respectively. Staging was: single organ involvement (uni/multifocal) - 69% and multisystem disease in 31%. Clinical re-evaluation of these cases is being done at the moment. The median follow up was 5 years (1 month – 11 years) and the overall survival was 92%. Currently 19% are alive without signs of disease; 44% are alive with disease; 25% are under treatment and 12% died.Discussion: These results agree with published literature. Considering the actual guidelines 56% patients were incompletely staged, which probably lead to suboptimal treatment. There is heterogeneity of clinical procedures aiming at staging and treatment of these patients.Conclusion: The diagnosis of adulthood Langerhans cell histiocytosis is difficult considering the diversity of clinical behavior. Frequently this also leads to diagnosis delay. Prospective international clinical trials enrolling adult patients are important.Keywords: Adult; Histiocytosis, Langerhans-Cell. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-12-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360 oai:ojs.www.actamedicaportuguesa.com:article/5360 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/5360 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/4149 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/4248 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7167 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7168 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7169 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5360/7451 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf image/jpeg image/jpeg image/jpeg application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 726-730 Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 726-730 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130642167889920 |